For the nine months ended September 30, 2026, Ecovyst reported sales of $773.6 million, up 47.6%, gross profit of $145.0 million and operating income of $61.1 million; Calabrian contributed to higher volume.
ECVT · Ecovyst Inc.
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Up next
Latest documents
Ecovist raised full-year 2026 adjusted EBITDA guidance to $208 to $212 million after third-quarter sales reached $309 million and adjusted EBITDA reached $61 million. It also lifted adjusted free cash flow guidance to $50 million to $60 million.
Ecovyst reported third-quarter sales of $308.6 million, up 51%, and Adjusted EBITDA of $61.2 million, up 6%, as it raised 2026 Adjusted EBITDA guidance to $208 million to $212 million.
Ecovyst Inc. approved its Second Amended and Restated Severance Plan effective October 22, 2026, providing executive officers 52 weeks of Compensation and the CEO 104 weeks. Change-in-control severance is 18 months for non-CEO officers and 30 months for the CEO.
Metrics snapshot
Useful current figures from the complete screener profile.
AI Brief
Q3 FY26 earnings call · Nov 5, 2026TL;DR. Ecovyst delivered strong third-quarter sales and earnings growth, raised full-year sales, Adjusted EBITDA, Adjusted Free Cash Flow and adjusted earnings guidance, and expects positive demand with Calabrian integration and synergies on track. Offsets included lower margins, higher costs, weaker nine-month Adjusted Free Cash Flow, higher net leverage, expected lower fourth-quarter virgin acid volume, increased spending and depreciation guidance, and outage and destocking risks.
- + Demand is expected to remain positive, supported by high refinery utilization, strong alkylate demand, copper mining and Canadian gold mine operating rates. new
- + Calabrian integration and the delivery of expected synergies remain on track. new
- + A turnaround previously planned for the fourth quarter was deferred to early 2027, reducing expected 2026 cost by approximately $3 million. new
- − Nine-month Adjusted Free Cash Flow declined to $32.4 million from $42.4 million, reflecting higher capital expenditures and sulfur-related working-capital use. new
- − Fourth-quarter virgin sulfuric acid volume is expected to be lower than in the prior-year quarter. new
- − Unplanned refining outages and potential customer destocking remain outlook risks. new
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Diluted Income per share non-GAAP | $0.21 | second quarter 2026 | — |
| Adjusted EBITDA non-GAAP | $53.1M | second quarter 2026 | — |
| Adjusted EBITDA from continuing operations non-GAAP | $201.7M | Trailing twelve months ended June 30, 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net income from continuing operations $25.8M
+$27.5M Provision for income taxes
+$24.1M Interest expense, net
+$81.5M Depreciation and amortization
+$5.6M Debt modification and extinguishment costs
+$7.7M Net loss on asset disposals
+$10.5M Transaction and other related costs
+$10.3M Equity-based compensation
+$4.8M Restructuring, integration and business optimization expenses
+$3.9M Other
= Adjusted EBITDA from continuing operations $201.7M
|
|||
| Adjusted EBITDA from continuing operations margin non-GAAP | 21.2% | Three months ended June 30, 2026 | — |
| Adjusted Free Cash Flow non-GAAP | $12.8M | six months ended June 30, 2026 | — |
| Adjusted Net Income non-GAAP | $35.6M | Six months ended June 30, 2026 | — |
| Free Cash Flow non-GAAP | $6.5M | Six months ended June 30, 2026 | — |
| Net debt | $409.3M | June 30, 2026 | — |
| Net Debt Leverage Ratio | 2 | June 30, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ECVT
this stock
Ecovyst Inc.
|
$1.15B | +8.5% | +20.9% | 33.0 | 6.1% |
|
LIN
Linde PLC
|
$240.31B | +22.8% | +3.0% | 34.7 | 1.4% |
|
AIQUF
L Air Liquide SA
|
$135.80B | +13.3% | — | — | 0.0% |
|
ECL
Ecolab Inc.
|
$86.50B | +17.5% | +2.2% | 42.0 | 1.5% |
|
SHW
Sherwin Williams Co
|
$84.69B | +8.2% | +2.1% | 32.3 | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Nov 5, 2026
- This year
- 16
For the nine months ended September 30, 2026, Ecovyst reported sales of $773.6 million, up 47.6%, gross profit of $145.0 million and operating income of $61.1 million; Calabrian contributed to higher volume.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ECVT | -1.9% | +4.2% | -24.4% | +4.4% | +8.5% |
| SPY | -1.7% | -3.5% | -1.4% | -2.1% | +8.5% |
| vs SPY | -0.2% | +7.7% | -23.0% | +6.4% | +0.0% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.